December 2011 - Class Action Blog Archive
A class action lawsuit is pending in California against JPMorgan Chase Bank, N.A. (or Chase Home Finance, LLC.) for the improper setting of loan interest rates.
A team of scientists at Children’s Hospital Boston has created a mathematical model to predict adverse drug effects in newly-created prescription drugs, according to US News.
Despite claims of “superior engineering” and “heavy-duty” craftsmanship, Fluidmaster No-Burst braided stainless steel supply lines may be prone to leaks or bursts.
A St. Louis newspaper has come under fire for its decision to cut health benefits for union retirees. The St. Louis Post-Dispatch—already entangled in a legal action from the Newspaper Guild over retiree benefits—now must contend with a second lawsuit filed by a union representing its mailroom workers.
An October article in Bloomberg addressed the FDA’s 510(k) pre-market clearance process as it has pertained to vaginal mesh over the years. This process only requires that medium-risk devices be “substantially equivalent” to devices that are currently on the market, after which no further testing or investigation is implemented. Below is an infographic illustrating a portion of vaginal mesh’s history with the FDA’s 510(k) clearance process.
In the wake of the BP oil disaster, some compensation methods of oil and gas companies have come under heightened scrutiny. One of these practices is when companies pay engineers or workers “day rates,” which is when employees are paid a certain amount per day disregarding the number of hours worked.
Eight different couples have filed a lawsuit against Pfizer, claiming that the ingestion of its popular anti-depressant, Zoloft, during pregnancy causes birth defects.
Last week, an Ohio man filed a Propecia lawsuit against Merck, claiming that the male pattern baldness drug caused him to develop permanent sexual dysfunction and also resulted in cognitive impairment.